A citation-based method for searching scientific literature

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, Jean-Claude Tardif, Subodh Verma, Christie M Ballantyne. J Am Heart Assoc 2022
Times Cited: 3







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
100

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao,[...]. Circulation 2021
8
100

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki, Yuji Matsuzawa, Yasushi Saito, Yuichi Ishikawa, Shinichi Oikawa, Jun Sasaki, Hitoshi Hishida, Hiroshige Itakura,[...]. Lancet 2007
100

Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
Are Annesønn Kalstad, Peder Langeland Myhre, Kristian Laake, Sjur Hansen Tveit, Erik Berg Schmidt, Paal Smith, Dennis Winston Trygve Nilsen, Arnljot Tveit, Morten Wang Fagerland, Svein Solheim,[...]. Circulation 2021
77
100

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Stephen J Nicholls, A Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M Ballantyne, Philip J Barter, Michael H Davidson, John J P Kastelein, Wolfgang Koenig, Darren K McGuire,[...]. JAMA 2020
221
100

Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography.
Suvasini Lakshmanan, Chandana Shekar, April Kinninger, Suraj Dahal, Afiachukwu Onuegbu, Andrew N Cai, Sajad Hamal, Divya Birudaraju, Sion K Roy, John R Nelson,[...]. Cardiovasc Res 2020
21
66

Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
Andrew P Ambrosy, Umar I Malik, Rachel C Thomas, Rishi V Parikh, Thida C Tan, Choon H Goh, Van N Selby, Matthew D Solomon, Harshith R Avula, Jesse K Fitzpatrick,[...]. Am Heart J 2021
6
66

Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma.
Ryo Nishio, Toshiro Shinke, Hiromasa Otake, Masayuki Nakagawa, Ryoji Nagoshi, Takumi Inoue, Amane Kozuki, Hirotoshi Hariki, Tsuyoshi Osue, Yu Taniguchi,[...]. Atherosclerosis 2014
80
66

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin.
R Preston Mason, Hazem Dawoud, Robert F Jacob, Samuel C R Sherratt, Tadeusz Malinski. Biomed Pharmacother 2018
41
66

Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study.
Kazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, Masahito Kajiya, Keisuke Okawa, Saori Tsukuda, Fumi Yokohama, Masahiro Sogo, Tomoyuki Nishibe, Naoaki Matsuo,[...]. Int J Cardiol 2017
47
66

Effects of combination lipid therapy in type 2 diabetes mellitus.
Henry N Ginsberg, Marshall B Elam, Laura C Lovato, John R Crouse, Lawrence A Leiter, Peter Linz, William T Friedewald, John B Buse, Hertzel C Gerstein, Jeffrey Probstfield,[...]. N Engl J Med 2010
66

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles.
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, John Gregson, Stuart J Pocock, Christie M Ballantyne. J Am Coll Cardiol 2019
49
66

EPA and DHA containing phospholipids have contrasting effects on membrane structure.
Samuel C R Sherratt, Rebecca A Juliano, Christina Copland, Deepak L Bhatt, Peter Libby, R Preston Mason. J Lipid Res 2021
7
66

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.
Brian Olshansky, Mina K Chung, Matthew J Budoff, Sephy Philip, Lixia Jiao, Ralph T Doyle, Christina Copland, Alex Giaquinto, Rebecca A Juliano, Deepak L Bhatt. Eur Heart J Suppl 2020
25
66


Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies.
Harold E Bays, Christie M Ballantyne, Rene A Braeckman, William G Stirtan, Paresh N Soni. Am J Cardiovasc Drugs 2013
95
66

Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).
Rene A Braeckman, Mehar S Manku, Harold E Bays, William G Stirtan, Paresh N Soni. Prostaglandins Leukot Essent Fatty Acids 2013
41
66

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Matthew J Budoff, Deepak L Bhatt, April Kinninger, Suvasini Lakshmanan, Joseph B Muhlestein, Viet T Le, Heidi T May, Kashif Shaikh, Chandana Shekar, Sion K Roy,[...]. Eur Heart J 2020
126
66

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Theingi Aung, Jim Halsey, Daan Kromhout, Hertzel C Gerstein, Roberto Marchioli, Luigi Tavazzi, Johanna M Geleijnse, Bernhard Rauch, Andrew Ness, Pilar Galan,[...]. JAMA Cardiol 2018
362
66

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability.
Samuel C R Sherratt, Hazem Dawoud, Deepak L Bhatt, Tadeusz Malinski, R Preston Mason. Prostaglandins Leukot Essent Fatty Acids 2021
10
66

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.
R Preston Mason, Peter Libby, Deepak L Bhatt. Arterioscler Thromb Vasc Biol 2020
119
66

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Coll Cardiol 2022
4
66

Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT.
Nickpreet Singh, Deepak L Bhatt, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, R Preston Mason, Christie M Ballantyne. J Am Coll Cardiol 2022
2
100

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.
Abbie L Cawood, Ren Ding, Frances L Napper, Ruth H Young, Jennifer A Williams, Matthew J A Ward, Ola Gudmundsen, Runar Vige, Simon P K Payne, Shu Ye,[...]. Atherosclerosis 2010
150
66

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.
Tetsu Watanabe, Kaoru Ando, Hyuma Daidoji, Yoichiro Otaki, Shigeo Sugawara, Motoyuki Matsui, Eiichiro Ikeno, Osamu Hirono, Hiroshi Miyawaki, Yoshinori Yashiro,[...]. J Cardiol 2017
81
66

Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study.
Masayuki Doi, Kazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, Masahito Kajiya, Keisuke Okawa, Rie Nakayama, Wataru Takagi, Ko Takeda, Satoshi Hirohata,[...]. Int J Cardiol 2014
35
66

Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. Circulation 2021
24
66

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. J Am Coll Cardiol 2019
145
66

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Michael Miller, Jean-Claude Tardif, Steven B Ketchum, Ralph T Doyle, Sabina A Murphy, Paresh N Soni,[...]. Clin Cardiol 2017
112
66

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Yasushi Saito, Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki, Yuji Matsuzawa, Yuichi Ishikawa, Shinichi Oikawa, Jun Sasaki, Hitoshi Hishida, Hiroshige Itakura,[...]. Atherosclerosis 2008
212
66

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Ph Gabriel Steg, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. Circulation 2020
66
66

Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis.
Jennifer M Monk, Tim Y Hou, Harmony F Turk, Brad Weeks, Chaodong Wu, David N McMurray, Robert S Chapkin. PLoS One 2012
64
33

A Revolution in Omega-3 Fatty Acid Research.
Deepak L Bhatt, Matthew J Budoff, R Preston Mason. J Am Coll Cardiol 2020
11
33

COVID-19: the vasculature unleashed.
Laure-Anne Teuwen, Vincent Geldhof, Alessandra Pasut, Peter Carmeliet. Nat Rev Immunol 2020
505
33

Effects of Eicosapentaenoic Acid on the Cytoprotection Through Nrf2-Mediated Heme Oxygenase-1 in Human Endothelial Cells.
Seung Eun Lee, Gun-Dong Kim, Hana Yang, Gun Woo Son, Hye Rim Park, Jeong-Je Cho, Hyun-Jong Ahn, Cheung-Seog Park, Yong Seek Park. J Cardiovasc Pharmacol 2015
16
33


Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Jeanette Erdmann, Klaus Stark, Ulrike B Esslinger, Philipp Moritz Rumpf, Doris Koesling, Cor de Wit, Frank J Kaiser, Diana Braunholz, Anja Medack, Marcus Fischer,[...]. Nature 2013
179
33

An increase in the EPA/AA ratio is associated with improved arterial stiffness in obese patients with dyslipidemia.
Ryo Ito, Noriko Satoh-Asahara, Hajime Yamakage, Yousuke Sasaki, Shinji Odori, Shigeo Kono, Hiromichi Wada, Takayoshi Suganami, Yoshihiro Ogawa, Koji Hasegawa,[...]. J Atheroscler Thromb 2014
34
33



Heme oxygenase-1: unleashing the protective properties of heme.
Leo E Otterbein, Miguel P Soares, Kenichiro Yamashita, Fritz H Bach. Trends Immunol 2003
941
33

Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation.
Miguel P Soares, Mark P Seldon, Isabel Pombo Gregoire, Tatiana Vassilevskaia, Pascal O Berberat, Jia Yu, Tung-Yu Tsui, Fritz H Bach. J Immunol 2004
337
33

Preferential Incorporation of Administered Eicosapentaenoic Acid Into Thin-Cap Atherosclerotic Plaques.
Tomohito Sato, Makoto Horikawa, Shiro Takei, Fumiyoshi Yamazaki, Takashi K Ito, Takeshi Kondo, Takanobu Sakurai, Tomoaki Kahyo, Koji Ikegami, Shumpei Sato,[...]. Arterioscler Thromb Vasc Biol 2019
24
33

Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner.
Anandita Pal, Abrar E Al-Shaer, William Guesdon, Maria J Torres, Michael Armstrong, Kevin Quinn, Traci Davis, Nichole Reisdorph, P Darrell Neufer, Espen E Spangenburg,[...]. FASEB J 2020
29
33


Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.
Mary F Walter, Robert F Jacob, Rebekah E Bjork, Barrett Jeffers, Jan Buch, Yoshiko Mizuno, R Preston Mason. J Am Coll Cardiol 2008
43
33



Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
Louise Bowman, Marion Mafham, Karl Wallendszus, Will Stevens, Georgina Buck, Jill Barton, Kevin Murphy, Theingi Aung, Richard Haynes, Jolyon Cox,[...]. N Engl J Med 2018
326
33

Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome.
Yuji Nishizaki, Kazunori Shimada, Shigemasa Tani, Takayuki Ogawa, Jiro Ando, Masao Takahashi, Masato Yamamoto, Tomohiro Shinozaki, Katsumi Miyauchi, Ken Nagao,[...]. Am J Cardiol 2014
45
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.